Bristol-Myers Squibb Comany
Records under this name other than patents Bristol-Myers Squibb Comany holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 1 of 1 · Back to Bristol-Myers Squibb Comany
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,199,149 | Monocyclic and bicyclic lactams as factor Xa inhibitors Term ended Term ended Dec 7, 2024 · USPTO record | Term ended | Term ended Dec 7, 2024 | USPTO record |